Skip to main content
European Commission logo
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

SAFETY TESTING IN THE LIFE CYCLE OF NANOTECHNOLOGY-ENABLED MEDICAL TECHNOLOGIES FOR HEALTH.

Descrizione del progetto

Un banco di prova per valutare i dispositivi medici basati su nanotecnologie

Il ricorso alla nanotecnologia è sempre più frequente nello sviluppo dei dispositivi medici. Come per tutte le innovazioni tecnologiche che trovano applicazione nel settore sanitario, è necessaria un’attenta valutazione di rischi e benefici potenziali. Il progetto SAFE-N-MEDTECH, finanziato dall’UE, svilupperà una piattaforma a libero accesso allo scopo di fornire competenze, reti e servizi necessari per lo sviluppo di dispositivi medici e diagnostici basati su nanotecnologie. La piattaforma SAFE-N-MEDTECH si rivolgerà ad aziende e laboratori, fornendo un approccio integrato per valutare requisiti, normative, biocompatibilità oltre alle proprietà dei nanomateriali. L’implementazione della piattaforma velocizzerà l’accesso al mercato delle tecnologie mediche basate su nanotecnologie.

Obiettivo

Society and clinical practice pose a growing demand on novel biomaterials, ICT, micro and nanotechnologies for innovative medical devices and in vitro diagnostics (Medical Technologies-MTs). In addition to the challenge of time, the new technologies are subjected to other pressing factors such as qualification, regulation, cost, biocompatibility and the need to be applicable worldwide. In the most recent years it is obvious that nano-enabled MTs can be applied in nearly every medical area, with a major presence and increased importance in cancer, regenerative medicine, advanced therapies, neurology, cardiology, orthopaedics, and dentistry. On the other hand, any innovation in the Health sector has to be carefully assessed in terms of risk/benefit ratio. Nano-enabled MTs particularly require careful assessment, since they are complex products group and their technological assessments are still under development. This assessment will be a key pillar for the here proposed Open Innovation Test Bed (OITB)
To address all the aforementioned challenges, the SAFE-N-MEDTECH consortium aims to bring a strong and competitive cooperation to compete in the market for a coordinated OITB for nano-enabled MTs. SAFE-N-MEDTECH will build an innovative open access platform to offer to companies and reference laboratories, the capabilities, knowhow, networks and services required for the development, testing, assessment, upscaling and market exploitation of nanotechnology-based Medical and Diagnosis Devices. This across the whole Life Cycle. This OITB will offer a multidisciplinary and market oriented innovation approach to SME´s, Healthcare providers and Industries for the translation to the market of MTs, based on a deep understanding and knowledge of the material-nanoproperties, their advance use and applications in MTs and other aspects involved in MTs safety (electric compatibility, electromagnetic properties, etc).

Invito a presentare proposte

H2020-NMBP-TO-IND-2018-2020

Vedi altri progetti per questo bando

Bando secondario

H2020-NMBP-HUBS-2018

Meccanismo di finanziamento

IA - Innovation action

Coordinatore

FUNDACION VASCA DE INNOVACION E INVESTIGACION SANITARIAS
Contribution nette de l'UE
€ 157 556,31
Indirizzo
RONDA DE AZKUE,1
48902 Barakaldo
Spagna

Mostra sulla mappa

Regione
Noreste País Vasco Bizkaia
Tipo di attività
Research Organisations
Collegamenti
Costo totale
€ 157 556,31

Partecipanti (36)